May 30, 2019
1 min watch
Save

VIDEO: Steroid insert shown to be safe, effective

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, Sydney L. Tyson, MD, MPH, discusses phase 3 study results of the Dextenza intracanalicular dexamethasone insert (Ocular Therapeutix) to control pain and inflammation following surgery.